These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

851 related items for PubMed ID: 10945642

  • 21. Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway.
    Wang Z, Wang M, Carr BI.
    J Cell Physiol; 2005 Jun; 203(3):510-9. PubMed ID: 15534860
    [Abstract] [Full Text] [Related]

  • 22. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
    Hamasuna R, Kataoka H, Moriyama T, Itoh H, Seiki M, Koono M.
    Int J Cancer; 1999 Jul 19; 82(2):274-81. PubMed ID: 10389763
    [Abstract] [Full Text] [Related]

  • 23. Hepatocyte growth factor exerts multiple biological functions on bovine mammary epithelial cells.
    Accornero P, Martignani E, Macchi E, Baratta M.
    J Dairy Sci; 2007 Sep 19; 90(9):4289-96. PubMed ID: 17699048
    [Abstract] [Full Text] [Related]

  • 24. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.
    Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W.
    Oncogene; 1992 Nov 19; 7(11):2195-206. PubMed ID: 1331934
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of hypoxia/reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: role of PI3-K and Akt kinase upon rac1.
    Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S.
    Cell Death Differ; 2003 May 19; 10(5):508-15. PubMed ID: 12728249
    [Abstract] [Full Text] [Related]

  • 26. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
    Wang SY, Chen B, Zhan YQ, Xu WX, Li CY, Yang RF, Zheng H, Yue PB, Larsen SH, Sun HB, Yang X.
    J Hepatol; 2004 Aug 19; 41(2):267-73. PubMed ID: 15288476
    [Abstract] [Full Text] [Related]

  • 27. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP, Mars WM, Pediaditakis P, Bell A, Mulé K, Bowen WC, Wang X, Zarnegar R, Michalopoulos GK.
    Cancer Res; 2002 Apr 01; 62(7):2064-71. PubMed ID: 11929826
    [Abstract] [Full Text] [Related]

  • 28. Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1.
    Recio JA, Merlino G.
    Oncogene; 2002 Feb 07; 21(7):1000-8. PubMed ID: 11850817
    [Abstract] [Full Text] [Related]

  • 29. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
    Weimar IS, Miranda N, Muller EJ, Hekman A, Kerst JM, de Gast GC, Gerritsen WR.
    Exp Hematol; 1998 Aug 07; 26(9):885-94. PubMed ID: 9694510
    [Abstract] [Full Text] [Related]

  • 30. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.
    Cao B, Su Y, Oskarsson M, Zhao P, Kort EJ, Fisher RJ, Wang LM, Vande Woude GF.
    Proc Natl Acad Sci U S A; 2001 Jun 19; 98(13):7443-8. PubMed ID: 11416216
    [Abstract] [Full Text] [Related]

  • 31. Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo.
    Uchinokura S, Miyata S, Fukushima T, Itoh H, Nakano S, Wakisaka S, Kataoka H.
    Int J Cancer; 2006 Feb 01; 118(3):583-92. PubMed ID: 16106403
    [Abstract] [Full Text] [Related]

  • 32. HGF-mediated apoptosis via p53/bax-independent pathway activating JNK1.
    Conner EA, Teramoto T, Wirth PJ, Kiss A, Garfield S, Thorgeirsson SS.
    Carcinogenesis; 1999 Apr 01; 20(4):583-90. PubMed ID: 10223185
    [Abstract] [Full Text] [Related]

  • 33. Molecular characteristics of HGF-SF and its role in cell motility and invasion.
    Weidner KM, Hartmann G, Naldini L, Comoglio PM, Sachs M, Fonatsch C, Rieder H, Birchmeier W.
    EXS; 1993 Apr 01; 65():311-28. PubMed ID: 8380739
    [Abstract] [Full Text] [Related]

  • 34. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.
    Oncogene; 2007 Aug 16; 26(38):5577-86. PubMed ID: 17369861
    [Abstract] [Full Text] [Related]

  • 35. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 36. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
    Slørdahl TS, Denayer T, Moen SH, Standal T, Børset M, Ververken C, Rø TB.
    Eur J Haematol; 2013 Nov 01; 91(5):399-410. PubMed ID: 23952536
    [Abstract] [Full Text] [Related]

  • 37. Matriptase is required for the active form of hepatocyte growth factor induced Met, focal adhesion kinase and protein kinase B activation on neural stem/progenitor cell motility.
    Fang JD, Lee SL.
    Biochim Biophys Acta; 2014 Jul 01; 1843(7):1285-94. PubMed ID: 24685580
    [Abstract] [Full Text] [Related]

  • 38. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
    Sakata H, Takayama H, Sharp R, Rubin JS, Merlino G, LaRochelle WJ.
    Cell Growth Differ; 1996 Nov 01; 7(11):1513-23. PubMed ID: 8930401
    [Abstract] [Full Text] [Related]

  • 39. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
    Jankowski K, Kucia M, Wysoczynski M, Reca R, Zhao D, Trzyna E, Trent J, Peiper S, Zembala M, Ratajczak J, Houghton P, Janowska-Wieczorek A, Ratajczak MZ.
    Cancer Res; 2003 Nov 15; 63(22):7926-35. PubMed ID: 14633723
    [Abstract] [Full Text] [Related]

  • 40. Hepatocyte growth factor promotes cell survival from fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression.
    Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, Shiraki K.
    Hepatology; 2000 Oct 15; 32(4 Pt 1):796-802. PubMed ID: 11003625
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 43.